Your browser doesn't support javascript.
loading
Differences in efficacy and safety among CAR-Ts anti-CD19/CD22, anti-CD19, and anti-CD22, in adult patients with relapse/refractory B-cell acute lymphoblastic leukemia: a meta-analysis and systematic review.
Becerril-Rico, Jared; Delgado-Montes, Yerenia A; Ortiz-Sánchez, Elizabeth.
Affiliation
  • Becerril-Rico J; Subdirección de investigación Básica, Instituto Nacional de Cancerología, Secretaría de Salud, Ciudad de México, México.
  • Delgado-Montes YA; Programa de posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Ciudad de México, México.
  • Ortiz-Sánchez E; Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Ciudad de México, México.
Leuk Lymphoma ; 64(11): 1822-1831, 2023.
Article in En | MEDLINE | ID: mdl-37548560
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Receptors, Chimeric Antigen Type of study: Systematic_reviews Limits: Adult / Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Receptors, Chimeric Antigen Type of study: Systematic_reviews Limits: Adult / Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2023 Document type: Article Country of publication: